Healthpeak Properties (DOC) is moving higher after publishing first-quarter 2026 results and lifting its full-year 2026 outlook, a combination that investors typically treat as a confidence signal for a REIT’s cash-flow trajectory. The update also put fresh focus on the company’s senior-housing strategy via Janus Living, including the recently completed IPO and a pipeline of additional acquisitions at the Janus platform.

For Q1 2026, Healthpeak reported net income of $0.28 per share and disclosed key REIT cash-flow metrics including Nareit FFO of $0.42 per share and FFO as Adjusted of $0.45 per share. The company said it is updating (raising) its full-year 2026 guidance ranges and tied the improved outlook to multiple factors including the Janus Living IPO, capital allocation actions, and Q1 performance.

The company highlighted that Janus Living completed its IPO in March 2026 with approximately $880 million of net proceeds and that Healthpeak remains the largest shareholder with an 81.6% ownership stake (as of the IPO). Healthpeak also disclosed it repurchased about 5.9 million shares in April 2026 for roughly $100 million at a weighted-average price of $16.81, which can support per-share metrics when executed at attractive valuations.

Traders will be watching whether the raised 2026 guidance holds up as interest-rate expectations and healthcare real-estate fundamentals evolve, especially in the lab and outpatient segments. Additional attention is likely to center on Janus Living’s acquisition pace (including reported contracts for incremental senior-housing deals) and whether Healthpeak continues to deploy its remaining authorization under the $500 million share repurchase program.